Showing results (91-100 of 344) with videos related to

Sort By:
Pageof 35
Optics Express|September 13, 2019
Image reconstruction and enhancement by deconvolution in scatter-plate microscopyStephan Ludwig, Benjamin Le Teurnier, Giancarlo Pedrini, et al.
Nano Letters|June 10, 2020
Spiky Nanostructures with Geometry-matching Topography for Virus InhibitionChuanxiong Nie, Marlena Stadtmüller, Hua Yang, et al.
Scientific Data|December 5, 2024
Electron microscopy images and morphometric data of SARS-CoV-2 variants in ultrathin plastic sectionsTobias Hoffmann, Janine Michel, Andreas Nitsche, et al.
Virology|January 25, 2011
Pathogenicity of different PR8 influenza A virus variants in mice is determined by both viral and host factorsPaulina Blazejewska, Lukasz Koscinski, Nuno Viegas, et al.
Pharmaceutics|September 23, 2022
The MEK1/2 Inhibitor ATR-002 (Zapnometinib) Synergistically Potentiates the Antiviral Effect of Direct-Acting Anti-SARS-CoV-2 DrugsAndré Schreiber, Benjamin Ambrosy, Oliver Planz, et al.
Cellular Microbiology|November 12, 2019
Type I interferon antagonistic properties of influenza B virus polymerase proteinsAndré Schreiber, Swantje Liedmann, Linda Brunotte, et al.
International Journal of Molecular Sciences|June 2, 2021
Altered Signal Transduction in the Immune Response to Influenza Virus and S. pneumoniae or S. aureus Co-InfectionsJanine J Wilden, Jasmin C Jacob, Christina Ehrhardt, et al.
Cellular Microbiology|January 10, 2008
The proapoptotic influenza A virus protein PB1-F2 regulates viral polymerase activity by interaction with the PB1 proteinIgor Mazur, Darisuren Anhlan, David Mitzner, et al.
Drug Resistance Updates : Reviews and Commentaries in Antimicrobial and Anticancer Chemotherapy|January 25, 2026
Inhibitors of cellular RSK isoforms exhibit anti-SARS-CoV-2 activity, enhance efficacy of direct-acting antivirals, and suppress emergence of resistanceAndré Schreiber, Benjamin Ambrosy, Darisuren Anhlan, et al.
Viruses|October 26, 2021
Metabolic Modifications by Common Respiratory Viruses and Their Potential as New Antiviral TargetsJens Kleinehr, Janine J Wilden, Yvonne Boergeling, et al.
Pageof 35